VRNA Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-02-02 | Rickard Kathleen A. | officer: Chief Medical Officer | 3,077,312 | S-Sale | D | 28,752 | 2.53 | 72,685.06 |
| 2023-02-01 | Hahn Mark W | officer: Chief Financial Officer | 16,432,312 | S-Sale | D | 413,168 | 2.56 | 1,056,553.21 |
| 2023-02-01 | Poll Claire | officer: General Counsel | 774,256 | S-Sale | D | 152,000 | 2.59 | 394,272.80 |
| 2023-02-01 | Poll Claire | officer: General Counsel | 926,256 | G-Gift | A | 152,000 | 0.00 | 0.00 |
| 2023-02-01 | Poll Claire | officer: General Counsel | 2,059,439 | G-Gift | D | 152,000 | 0.00 | 0.00 |
| 2023-02-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 17,342,872 | S-Sale | D | 432,928 | 2.56 | 1,107,083.48 |
| 2023-02-01 | Rickard Kathleen A. | officer: Chief Medical Officer | 3,106,064 | S-Sale | D | 89,960 | 2.56 | 230,045.71 |
| 2023-01-20 | Poll Claire | officer: General Counsel | 8,328 | M-Exempt | D | 58,280 | 0.00 | 0.00 |
| 2023-01-20 | Poll Claire | officer: General Counsel | 0 | M-Exempt | D | 34,248 | 0.00 | 0.00 |
| 2023-01-20 | Poll Claire | officer: General Counsel | 2,211,439 | M-Exempt | A | 178,800 | 0.00 | 0.00 |
| 2023-01-20 | Rickard Kathleen A. | officer: Chief Medical Officer | 15,000 | M-Exempt | D | 105,000 | 0.00 | 0.00 |
| 2023-01-20 | Rickard Kathleen A. | officer: Chief Medical Officer | 3,196,024 | M-Exempt | A | 105,000 | 0.00 | 0.00 |
| 2022-12-23 | ORBIMED ADVISORS LLC | director | 34,085,528 | S-Sale | D | 92,992 | 24.11 | 2,242,037.12 |
| 2022-12-23 | ORBIMED ADVISORS LLC | director | 34,178,520 | S-Sale | D | 1,116,048 | 23.23 | 25,925,795.04 |
| 2022-12-23 | ORBIMED ADVISORS LLC | director | 35,294,568 | S-Sale | D | 961,328 | 22.27 | 21,408,774.56 |
| 2022-12-23 | Gupta Rishi | director | 34,085,528 | S-Sale | D | 92,992 | 24.11 | 2,242,037.12 |
| 2022-12-23 | Gupta Rishi | director | 34,178,520 | S-Sale | D | 1,116,048 | 23.23 | 25,925,795.04 |
| 2022-12-23 | Gupta Rishi | director | 35,294,568 | S-Sale | D | 961,328 | 22.27 | 21,408,774.56 |
| 2022-12-22 | Poll Claire | officer: General Counsel | 774,256 | S-Sale | D | 240,000 | 2.69 | 646,032.00 |
| 2022-12-22 | ORBIMED ADVISORS LLC | director | 36,255,896 | S-Sale | D | 684,696 | 22.07 | 15,111,240.72 |
| 2022-12-22 | ORBIMED ADVISORS LLC | director | 36,940,592 | S-Sale | D | 3,284,800 | 21.71 | 71,313,008.00 |
| 2022-12-22 | Gupta Rishi | director | 36,255,896 | S-Sale | D | 684,696 | 22.07 | 15,111,240.72 |
| 2022-12-22 | Gupta Rishi | director | 36,940,592 | S-Sale | D | 3,284,800 | 21.71 | 71,313,008.00 |
| 2022-12-20 | Hahn Mark W | officer: Chief Financial Officer | 16,845,480 | S-Sale | D | 600,000 | 2.12 | 1,269,060.00 |
| 2022-12-20 | ZACCARDELLI DAVID | director, officer: President and CEO | 17,775,800 | S-Sale | D | 600,000 | 2.12 | 1,269,600.00 |
| 2022-11-22 | Poll Claire | officer: General Counsel | 1,014,256 | G-Gift | A | 170,000 | 0.00 | 0.00 |
| 2022-11-22 | Poll Claire | officer: General Counsel | 2,032,639 | G-Gift | D | 170,000 | 0.00 | 0.00 |
| 2022-11-01 | Hahn Mark W | officer: Chief Financial Officer | 17,445,480 | S-Sale | D | 13,160 | 1.67 | 22,011.42 |
| 2022-11-01 | Hahn Mark W | officer: Chief Financial Officer | 17,458,640 | F-InKind | D | 454,856 | 1.60 | 727,769.60 |
| 2022-11-01 | Rickard Kathleen A. | officer: Chief Medical Officer | 3,091,024 | S-Sale | D | 28,752 | 1.64 | 47,124.53 |
| 2022-11-01 | Rickard Kathleen A. | officer: Chief Medical Officer | 3,119,776 | F-InKind | D | 56,264 | 1.60 | 90,022.40 |
| 2022-11-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 18,375,800 | S-Sale | D | 32,904 | 1.67 | 55,035.23 |
| 2022-11-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 18,408,704 | F-InKind | D | 454,856 | 1.60 | 727,769.60 |
| 2022-09-26 | ZACCARDELLI DAVID | director, officer: President and CEO | 18,863,560 | A-Award | A | 3,600,000 | 0.00 | 0.00 |
| 2022-09-26 | Hahn Mark W | officer: Chief Financial Officer | 17,913,496 | A-Award | A | 3,600,000 | 0.00 | 0.00 |
| 2022-09-26 | Poll Claire | officer: General Counsel | 2,563,055 | A-Award | A | 800,000 | 0.00 | 0.00 |
| 2022-09-26 | Rickard Kathleen A. | officer: Chief Medical Officer | 3,176,040 | A-Award | A | 800,000 | 0.00 | 0.00 |
| 2022-08-21 | Poll Claire | officer: General Counsel | 844,256 | G-Gift | A | 90,104 | 0.00 | 0.00 |
| 2022-08-21 | Poll Claire | officer: General Counsel | 2,202,639 | G-Gift | D | 90,104 | 0.00 | 0.00 |
| 2022-08-15 | Access Industries Holdings LLC | 10 percent owner | 55,911,648 | P-Purchase | A | 4,800,000 | 1.31 | 6,300,000.00 |
| 2022-08-09 | Hahn Mark W | officer: Chief Financial Officer | 14,313,496 | S-Sale | D | 600,000 | 1.75 | 1,050,000.00 |
| 2022-08-09 | ZACCARDELLI DAVID | director, officer: President and CEO | 15,263,560 | S-Sale | D | 600,000 | 1.75 | 1,050,000.00 |
| 2022-08-02 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,376,040 | S-Sale | D | 28,752 | 0.70 | 20,215.53 |
| 2022-08-01 | Poll Claire | officer: General Counsel | 1,763,055 | F-InKind | D | 79,896 | 0.67 | 53,730.06 |
| 2022-08-01 | Hahn Mark W | officer: Chief Financial Officer | 14,913,496 | S-Sale | D | 13,168 | 0.70 | 9,214.97 |
| 2022-08-01 | Hahn Mark W | officer: Chief Financial Officer | 14,926,664 | F-InKind | D | 454,856 | 0.67 | 305,890.66 |
| 2022-08-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 15,863,560 | S-Sale | D | 32,904 | 0.70 | 23,026.22 |
| 2022-08-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 15,896,464 | F-InKind | D | 454,864 | 0.67 | 305,896.04 |
| 2022-08-01 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,404,792 | F-InKind | D | 56,432 | 0.67 | 37,950.52 |
| 2022-05-22 | Poll Claire | officer: General Counsel | 754,152 | G-Gift | A | 90,104 | 0.00 | 0.00 |
| 2022-05-22 | Poll Claire | officer: General Counsel | 2,292,743 | G-Gift | D | 90,104 | 0.00 | 0.00 |
| 2022-05-03 | ZACCARDELLI DAVID | director, officer: President and CEO | 16,351,328 | S-Sale | D | 32,904 | 0.50 | 16,307.22 |
| 2022-05-03 | Hahn Mark W | officer: Chief Financial Officer | 15,381,520 | S-Sale | D | 12,512 | 0.50 | 6,200.95 |
| 2022-05-03 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,461,224 | S-Sale | D | 28,752 | 0.49 | 14,154.61 |
| 2022-05-01 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,489,976 | F-InKind | D | 56,432 | 0.52 | 29,485.72 |
| 2022-05-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 16,384,232 | F-InKind | D | 454,864 | 0.52 | 237,666.44 |
| 2022-05-01 | Hahn Mark W | officer: Chief Financial Officer | 15,394,032 | F-InKind | D | 432,128 | 0.52 | 225,786.88 |
| 2022-05-01 | Poll Claire | officer: General Counsel | 1,842,951 | F-InKind | D | 79,896 | 0.52 | 41,745.66 |
| 2022-04-28 | SHAH MAHENDRA | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-28 | Edwards Martin | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-28 | Sinha Vikas | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-28 | Deschamps Lisa | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-28 | EBSWORTH DAVID R | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-28 | Cunningham Kenneth | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-28 | Gupta Rishi | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-28 | Ullman Anders | director | 200,000 | A-Award | A | 200,000 | 0.50 | 100,760.00 |
| 2022-04-11 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,546,408 | S-Sale | D | 59,720 | 0.54 | 32,099.50 |
| 2022-04-08 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,606,128 | S-Sale | D | 112,800 | 0.59 | 66,382.80 |
| 2022-03-14 | Brady James Aloysius | director | 288,000 | A-Award | A | 288,000 | 0.60 | 173,520.00 |
| 2022-02-22 | Poll Claire | officer: General Counsel | 664,048 | G-Gift | A | 90,104 | 0.00 | 0.00 |
| 2022-02-22 | Poll Claire | officer: General Counsel | 2,382,847 | G-Gift | D | 90,104 | 0.00 | 0.00 |
| 2022-02-03 | ZACCARDELLI DAVID | director, officer: President and CEO | 16,839,096 | S-Sale | D | 52,056 | 0.73 | 37,771.83 |
| 2022-02-02 | Hahn Mark W | officer: Chief Financial Officer | 15,826,160 | S-Sale | D | 10,416 | 0.76 | 7,876.58 |
| 2022-02-01 | Deschamps Lisa | director | 70,320 | S-Sale | D | 11,664 | 0.78 | 9,068.76 |
| 2022-02-01 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,718,928 | F-InKind | D | 63,560 | 0.78 | 49,335.27 |
| 2022-02-01 | Poll Claire | officer: General Counsel | 1,922,847 | F-InKind | D | 79,896 | 0.78 | 62,023.26 |
| 2022-02-01 | Hahn Mark W | officer: Chief Financial Officer | 15,836,576 | F-InKind | D | 288,320 | 0.78 | 223,793.98 |
| 2022-02-01 | Hahn Mark W | officer: Chief Financial Officer | 16,124,896 | A-Award | A | 133,776 | 0.75 | 99,997.56 |
| 2022-02-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 16,891,152 | F-InKind | D | 288,648 | 0.78 | 224,077.44 |
| 2022-02-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 17,179,800 | A-Award | A | 334,448 | 0.75 | 249,999.88 |
| 2021-11-21 | Poll Claire | officer: General Counsel | 573,944 | G-Gift | A | 90,104 | 0.00 | 0.00 |
| 2021-11-21 | Poll Claire | officer: General Counsel | 2,472,951 | G-Gift | D | 90,104 | 0.00 | 0.00 |
| 2021-11-02 | Deschamps Lisa | director | 81,984 | S-Sale | D | 11,672 | 0.66 | 7,689.51 |
| 2021-11-02 | Hahn Mark W | officer: Chief Financial Officer | 15,991,120 | S-Sale | D | 10,416 | 0.65 | 6,721.44 |
| 2021-11-02 | ZACCARDELLI DAVID | director, officer: President and CEO | 16,845,352 | S-Sale | D | 52,056 | 0.64 | 33,373.10 |
| 2021-11-01 | Poll Claire | officer: General Counsel | 2,002,743 | F-InKind | D | 79,896 | 0.64 | 51,133.44 |
| 2021-11-01 | Rickard Kathleen A. | officer: Chief Medical Officer | 2,782,488 | F-InKind | D | 56,928 | 0.64 | 36,433.92 |
| 2021-11-01 | Hahn Mark W | officer: Chief Financial Officer | 16,001,536 | F-InKind | D | 454,848 | 0.64 | 291,102.72 |
| 2021-11-01 | ZACCARDELLI DAVID | director, officer: President and CEO | 16,897,408 | F-InKind | D | 454,848 | 0.64 | 291,102.72 |
| 2021-08-09 | SHAH MAHENDRA | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | Sinclair Andrew | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | Ullman Anders | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | Edwards Martin | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | Gupta Rishi | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | Cunningham Kenneth | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | Sinha Vikas | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | Deschamps Lisa | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-09 | EBSWORTH DAVID R | director | 64,000 | A-Award | A | 64,000 | 0.78 | 49,600.00 |
| 2021-08-04 | ZACCARDELLI DAVID | director, officer: President and CEO | 17,369,912 | S-Sale | D | 18,400 | 0.74 | 13,674.88 |
| 2021-08-03 | ZACCARDELLI DAVID | director, officer: President and CEO | 17,388,312 | S-Sale | D | 16,000 | 0.76 | 12,209.60 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.